ABT vs XIFR · P/E 25, rev $44.33B vs rev $1.19B
Abbott Laboratories (ABT) versus XPLR Infrastructure LP Unit (XIFR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
XPLR Infrastructure LP Unit (XIFR) is a utilities - renewable company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported XIFR revenue for 2025-12-31 was $1.19B. Net income was -$28.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. XIFR currently screens at market cap $814.0M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. XIFR currently screens at market cap $814.0M.
Not investment advice. Open the ABT and XIFR stock pages for the full models.
Not investment advice.